pCMV-FLAG LIP Citations (4)

Originally described in: C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.
Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J Cancer Cell. 2006 Sep . 10(3):203-14. PubMed Journal

---

Articles Citing pCMV-FLAG LIP

Articles
Tumor necrosis factor alpha- and interleukin-1beta-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Wang J, Tian Y, Phillips KL, Chiverton N, Haddock G, Bunning RA, Cross AK, Shapiro IM, Le Maitre CL, Risbud MV. Arthritis Rheum. 2013 Mar;65(3):832-42. doi: 10.1002/art.37819. PubMed
The CCAAT/enhancer-binding protein beta-2 isoform (CEBPbeta-2) upregulates galectin-7 expression in human breast cancer cells. Campion CG, Labrie M, Grosset AA, St-Pierre Y. PLoS One. 2014 May 2;9(5):e95087. doi: 10.1371/journal.pone.0095087. eCollection 2014. PubMed
COX-2 expression mediated by calcium-TonEBP signaling axis under hyperosmotic conditions serves osmoprotective function in nucleus pulposus cells. Choi H, Chaiyamongkol W, Doolittle AC, Johnson ZI, Gogate SS, Schoepflin ZR, Shapiro IM, Risbud MV. J Biol Chem. 2018 Jun 8;293(23):8969-8981. doi: 10.1074/jbc.RA117.001167. Epub 2018 Apr 26. PubMed
Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD. Sun X, Jefferson P, Zhou Q, Angelastro JM, Greene LA. Mol Cancer Res. 2020 Feb;18(2):216-228. doi: 10.1158/1541-7786.MCR-19-0631. Epub 2019 Nov 1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.